A Marburg fever outbreak in Equatorial Guinea is galvanizing efforts to test drugs and vaccines for a virus that currently has none. But every day counts, warned experts who gathered virtually on Tuesday to try to chart a course for the work.
Federal health agencies worked to get more nursing home residents and staff to take the latest Covid booster all winter, creating social media hashtags, putting money into vaccine hotlines and flagging the worst performing facilities to states.
But their decision to scale back on two vaccine interventions that were critical in getting residents and staff protected from Covid during the first vaccine rollout in late 2020 and 2021 has left the job mostly to facilities, resident advocates say, with disappointing results.
For older Americans, the pandemic still poses significant dangers. About three-quarters of Covid deaths have occurred in people over 65, with the greatest losses concentrated among those over 75.
Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.
“We all have to change our mindset to be much more agile and much more oriented towards building resilience at all levels, so we can handle the shocks better,” Kristalina Georgieva said Tuesday, during a World Government Summit panel hosted by CNBC’s Hadley Gamble.
Recent Comments